A novel reduced iron metal-organic framework nanoparticle with cytotoxicity specific to cancer cells is presented. This nanoparticle was prepared via a hydrothermal method, reduced using hydroquinone, and finally conjugated with folic acid (namely, rMOF-FA). The synthesized nanoparticle shows the controlled release of iron in an acidic ex-vivo environment. Iron present on the rMOF-FA and released into solution can react with high levels of hydrogen peroxide found specifically in cancer cells to increase the hydroxyl radical concentration. The hydroxyl radicals oxidize proteins, lipids, and/or DNA within the biological system to decrease cell viability. In vitro experiments demonstrate that this novel nanoparticle is cytotoxic to cancer cell...
Organic–inorganic nanohybrids are becoming popular for their potential biological applications, incl...
Precise manipulation of cancer cell death by harnessing reactive oxygen species (ROS) is a promising...
Heterogeneous catalysis has emerged as a promising alternative for the development of new cancer the...
© 2018 Dr. Hadi RanjiburachalooCancer which is the second greatest cause of death worldwide has reac...
Fenton cancer therapy as a new methodology for the treatment of tumour cells is largely restricted o...
Ferroptosis, as a newly discovered cell death form, has become an attractive target for precision ca...
Initiating localized catalytic chemical reactions in tumor microenvironment (TME) can achieve appeal...
Abstract Background Hepatocellular carcinoma is insensitive to many chemotherapeutic agents. Ferropt...
Chemodynamic therapy (CDT) can efficiently destroy tumor cells via Fenton reaction in the presence o...
Doxorubicin (DOX) is a widely used first-line antitumor agent; however, acquired drug resistance and...
© An urgent need in chemodynamic therapy (CDT) is to achieve high Fenton catalytic efficiency at sma...
Targeting damage to mitochondria has become an effective strategy antitumor therapies. Here, the aut...
In this work, a nanoplatform (FeCORM NPs) loaded with an iron-carbonyl complex was constructed. By e...
The upregulation of dihydroorotate dehydrogenase (DHODH) redox systems inside tumor cells provides a...
Inspired by the distinct metabolic pathway of tumor cells, here a new anti-cancer therapy (i.e., Cu-...
Organic–inorganic nanohybrids are becoming popular for their potential biological applications, incl...
Precise manipulation of cancer cell death by harnessing reactive oxygen species (ROS) is a promising...
Heterogeneous catalysis has emerged as a promising alternative for the development of new cancer the...
© 2018 Dr. Hadi RanjiburachalooCancer which is the second greatest cause of death worldwide has reac...
Fenton cancer therapy as a new methodology for the treatment of tumour cells is largely restricted o...
Ferroptosis, as a newly discovered cell death form, has become an attractive target for precision ca...
Initiating localized catalytic chemical reactions in tumor microenvironment (TME) can achieve appeal...
Abstract Background Hepatocellular carcinoma is insensitive to many chemotherapeutic agents. Ferropt...
Chemodynamic therapy (CDT) can efficiently destroy tumor cells via Fenton reaction in the presence o...
Doxorubicin (DOX) is a widely used first-line antitumor agent; however, acquired drug resistance and...
© An urgent need in chemodynamic therapy (CDT) is to achieve high Fenton catalytic efficiency at sma...
Targeting damage to mitochondria has become an effective strategy antitumor therapies. Here, the aut...
In this work, a nanoplatform (FeCORM NPs) loaded with an iron-carbonyl complex was constructed. By e...
The upregulation of dihydroorotate dehydrogenase (DHODH) redox systems inside tumor cells provides a...
Inspired by the distinct metabolic pathway of tumor cells, here a new anti-cancer therapy (i.e., Cu-...
Organic–inorganic nanohybrids are becoming popular for their potential biological applications, incl...
Precise manipulation of cancer cell death by harnessing reactive oxygen species (ROS) is a promising...
Heterogeneous catalysis has emerged as a promising alternative for the development of new cancer the...